|
TFRC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.29090000034316E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.18902673765342E-12 |
| Normal-vs-Stage2 |
2.564600E-03 |
| Normal-vs-Stage3 |
2.510200E-02 |
| Normal-vs-Stage4 |
3.828000E-01 |
| Stage1-vs-Stage2 |
3.874600E-01 |
| Stage1-vs-Stage3 |
4.747800E-02 |
| Stage1-vs-Stage4 |
1.390840E-01 |
| Stage2-vs-Stage3 |
4.200600E-01 |
| Stage2-vs-Stage4 |
3.057800E-01 |
| Stage3-vs-Stage4 |
6.755600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.2263527667028E-12 |
| Normal-vs-AfricanAmerican |
1.92760999999653E-05 |
| Normal-vs-Asian |
2.883400E-01 |
| Caucasian-vs-AfricanAmerican |
9.553600E-02 |
| Caucasian-vs-Asian |
4.316800E-01 |
| AfricanAmerican-vs-Asian |
8.842800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.48578935213573E-13 |
| Normal-vs-Female |
8.674400E-01 |
| Male-vs-Female |
3.258300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.40889999999694E-05 |
| Normal-vs-Extreme_Weight |
2.93419732955158E-11 |
| Normal-vs-Obese |
6.7300998107811E-10 |
| Normal-vs-Extreme_Obese |
2.817500E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.186190E-01 |
| Normal_Weight-vs-Obese |
2.839800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.916200E-01 |
| Extreme_Weight-vs-Obese |
4.820400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.525600E-01 |
| Obese-vs-Extreme_Obese |
8.974000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.722200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.01270003494136E-09 |
| Normal-vs-Age(61-80Yrs) |
2.58904009342587E-13 |
| Normal-vs-Age(81-100Yrs) |
8.30469999990591E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.744400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.624330E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.035500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.759800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.214200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.132400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.89610549483632E-11 |
| Normal-VS-KIRP CIMP |
5.680200E-02 |
| Normal-VS-Unclassified PRCC |
6.41780000000258E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.173800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.236320E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.551190E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.764090E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.350000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.43239999999645E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.74490446933373E-11 |
| Normal-vs-N1 |
4.137600E-01 |
| Normal-vs-N2 |
6.055700E-03 |
| N0-vs-N1 |
4.115200E-03 |
| N0-vs-N2 |
5.935000E-01 |
| N1-vs-N2 |
3.312200E-01 |
|
|
